Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2013
03/14/2013US20130065923 Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof
03/14/2013US20130065921 Pten inhibitor or maxi-k channels opener
03/14/2013US20130065920 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
03/14/2013US20130065919 Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
03/14/2013US20130065918 Soluble guanylate cyclase activators
03/14/2013US20130065917 Salt of naphthyridine carboxylic acid derivative
03/14/2013US20130065916 Crystalline forms of a 3-carboxypropyl-aminotetralin compound
03/14/2013US20130065914 Halogen or cyano substituted thieno [2,3-d]pyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
03/14/2013US20130065913 Novel compounds
03/14/2013US20130065911 N-(5-cycloalkyl- or 5-heterocyclyl-)-pyridin-3-yl carboxamides
03/14/2013US20130065910 Oral meclizine aqueous formulations with taste flavoring agent
03/14/2013US20130065909 Fatty acid fumarate derivatives and their uses
03/14/2013US20130065908 Dihydrofuro pyrimidines as akt protein kinase inhibitors
03/14/2013US20130065907 5-cycloalkyl- or 5-heterocyclyl-nicotinamides
03/14/2013US20130065906 New compounds, pharmaceutical compositions and uses thereof
03/14/2013US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
03/14/2013US20130065904 Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders
03/14/2013US20130065903 Method of Improving Diastolic Dysfunction
03/14/2013US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
03/14/2013US20130065901 2-aminopyridine analogs as glucokinase activators
03/14/2013US20130065900 Pharmaceutical compounds
03/14/2013US20130065899 Heteroaryl compounds and uses thereof
03/14/2013US20130065898 Use of dihydroimidazolones for the treatment of dogs
03/14/2013US20130065897 Compounds, preparation and uses thereof
03/14/2013US20130065896 Fused imidazole derivative
03/14/2013US20130065895 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction
03/14/2013US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS
03/14/2013US20130065893 Imidazole derivatives as aldosterone synthase inhibitors
03/14/2013US20130065892 Heteroaryl compounds and uses thereof
03/14/2013US20130065890 Pyrimidine derivatives
03/14/2013US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists
03/14/2013US20130065888 Ophthalmic formulations and processes for their preparation
03/14/2013US20130065887 Treatment of Cancer with Dopamine Receptor Antagonists
03/14/2013US20130065886 Administration of benzodiazepine compositions
03/14/2013US20130065885 Oral therapeutic compound delivery system
03/14/2013US20130065884 Anti-Infective Compounds
03/14/2013US20130065883 Triazolo [4, 5- B] Pyridin Derivatives
03/14/2013US20130065882 VLA-4 inhibitory drug
03/14/2013US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors
03/14/2013US20130065880 Compounds as tyrosine kinase modulators
03/14/2013US20130065879 Heteroaryl compounds and uses thereof
03/14/2013US20130065878 Cell-free preparation of carbapenems
03/14/2013US20130065877 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
03/14/2013US20130065876 3-pyridine carboxylic acid hydrazides
03/14/2013US20130065875 Small molecule inhibitors of hepatitis c virus
03/14/2013US20130065874 Methods for treating intrapulmonary infections
03/14/2013US20130065873 Metal complexes
03/14/2013US20130065872 Synthesis of syrbactin proteasome inhibitors
03/14/2013US20130065870 Treatment of pain with topical diclofenac
03/14/2013US20130065869 Ophthalmologic irrigation solutions and method
03/14/2013US20130065868 Anxioytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
03/14/2013US20130065867 Compositions and methods for using same for treating posterior blepharitis
03/14/2013US20130065866 Dentinal drug delivery composition and screening method
03/14/2013US20130065865 Barrier film-forming germicidal composition for controlling mastitis
03/14/2013US20130065864 Novel iridium/rhodium anti-cancer compounds
03/14/2013US20130065863 Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
03/14/2013US20130065862 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
03/14/2013US20130065861 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
03/14/2013US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators
03/14/2013US20130065859 Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
03/14/2013US20130065858 Compounds useful as raf kinase inhibitors
03/14/2013US20130065857 Novel dxr inhibitors for antimicrobial therapy
03/14/2013US20130065856 Tenofovir alafenamide hemifumarate
03/14/2013US20130065853 Contraceptive methods and compositions
03/14/2013US20130065852 Analysis of sulfated polysaccharides
03/14/2013US20130065851 Anti-viral formulations
03/14/2013US20130065850 Treatment of viral infections by modulation of host cell metabolic pathways
03/14/2013US20130065848 Levoisovalerylspiramycin i, ii or iii, preparations, prepartation methods and uses thereof
03/14/2013US20130065847 Endoparasiticidal compositions
03/14/2013US20130065846 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
03/14/2013US20130065845 Triazole Compounds and Methods of Making and Using the Same
03/14/2013US20130065844 Compositions of Stable Tiacumicins
03/14/2013US20130065843 Phenolic Compositions Derived From Apple Skin And Uses Thereof
03/14/2013US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF
03/14/2013US20130065839 Treatment of t-cell mediated diseases
03/14/2013US20130065836 Biomarker for gastric cancer
03/14/2013US20130065834 Modulators of proteasome activity
03/14/2013US20130065822 Compositions for masking the flavor of nutrients and methods for making same
03/14/2013US20130065818 Arylamide Compounds And Compositions And Uses Thereof
03/14/2013US20130065815 Fn 14/TRAIL Fusion Proteins
03/14/2013US20130065814 Inductive production of pluripotent stem cells using synthetic transcription factors
03/14/2013US20130065308 Cationic lipids
03/14/2013US20130064965 Implants for administering substances and methods of producing implants
03/14/2013US20130064913 Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
03/14/2013US20130064905 Method for Enhancing the Growth and Fullness of Hair
03/14/2013US20130064902 Phosphaplatins and their use for treatment of cancers
03/14/2013US20130064901 Gene expression profiling for classifying and treating gastric cancer
03/14/2013US20130064897 New process for producing hydrodispexible dry pharmaceutical composition and the pharmaceutical compositions thus obtained
03/14/2013US20130064896 Gastroretentive Solid Oral Dosage Forms with Swellable Hydrophilic Polymer
03/14/2013US20130064894 Novel cationic lipids and methods of use thereof
03/14/2013US20130064893 Stabilized pharmaceutical composition
03/14/2013US20130064892 Cellulosic gel material as a pharmaceutical excipient
03/14/2013US20130064891 Pharmaceutical compositions of nsaid and acid inhibitor
03/14/2013US20130064890 Pharmaceutical formulation based on ibuprofen and codeine having improved stability
03/14/2013US20130064889 Tablet-in-tablet Palperidone Formulations and Methods for Production and Use Thereof
03/14/2013US20130064888 Pharmaceutical formulations
03/14/2013US20130064887 Pharmaceutical compositions
03/14/2013US20130064884 Composition and method for treating ketosis in cows
03/14/2013US20130064883 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
03/14/2013US20130064881 Compositions and methods for treating prostate cancer
1 ... 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 ... 7860